Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases

BACKGROUND: To investigate mutational load and histologic biomarkers as prognostic factors in patients with chemorefractory colorectal liver metastases (CRLM) treated with Y-90 radioembolization therapy. MATERIALS AND METHODS: Single institution retrospective study of patients with CRLM who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Dendy, Meaghan S., Ludwig, Johannes M., Kokabi, Nima, Stein, Stacey M., Lacy, Jill, Hochster, Howard S., Kim, Hyun S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126695/
https://www.ncbi.nlm.nih.gov/pubmed/30197760
http://dx.doi.org/10.18632/oncotarget.25992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126695/
https://www.ncbi.nlm.nih.gov/pubmed/30197760
http://dx.doi.org/10.18632/oncotarget.25992

Ejemplares similares